Clinical Trials in Southeast Asia 2012

Clinical Trials in Southeast Asia 2012

 

  • Pharma and Biotech Delegates

    Sale Date Ended

    INR 7000
    Sold Out
  • Recognised Academic and Government Institutions

    Sale Date Ended

    INR 1500
    Sold Out
  • Recognised Academic and Government Institutions

    Sale Date Ended

    INR 1500
    Sold Out

Invite friends

Contact Us

Page Views : 547

About The Event

More and more companies in India are looking to conduct clinical trials in Southeast Asia due to the growing market potential, a well defined and speedy regulatory process and the high quality of clinical trials, compatible with USFDA and EMA requirements.

In fact Southeast Asia is one of the fastest emerging hub for Clinical Trials in the world. For more than a decade, the emerging markets of the Southeast Asia region have held special promise for the global biopharmaceutical industry. Driven by a combination of rapidly expanding economies, technological innovation and a talented workforce, the region has seen explosive growth in both economic and political power during the past 10 years.

​

A range of factors — from deregulation and better trade links, to improved access and the rise of medical tourism — have enabled markets such as Malaysia, Vietnam, Indonesia and others to take on increasingly important roles in this region. Countries such as Singapore and Malaysia have all identified the biopharmaceutical industry as a strategic sector worthy of public infrastructure investment and support.

Indian and multinational Big pharma and Biotech companies are taking their trials to Southeast Asia due to stringent regulatory approvals and increase in denials for conducting Clinical Trials in India.

​

The goal of this program is to showcase the potential of Clinical Trial scenario in Southeast Asia. The regulatory agencies, their expectations and their process for approvals are some of the key points in this conference. Delegates include Directors, VPs, Senior Medical Advisors and senior staff of Regulatory affairs from pharma and biotech companies and also couple of Clinical Research Organizations as solution providers with expertise in this region.

Venue Map